IMU 1.69% 6.0¢ imugene limited

Ann: Imugene Advances to Phase 2 in Gastric Cancer Trial, page-26

  1. Mer
    1,301 Posts.
    lightbulb Created with Sketch. 241
    Results December, another month for Long Term monitoring, ESMO conference 13 - 16th December, Josep Tabernero presenting on the 16th - Immune therapeutics in gastro and colorectal cancer.  Hope it all lines up nicely.

    Cheers.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
6.0¢
Change
0.001(1.69%)
Mkt cap ! $439.1M
Open High Low Value Volume
6.0¢ 6.1¢ 5.8¢ $1.072M 18.07M

Buyers (Bids)

No. Vol. Price($)
2 25799 6.0¢
 

Sellers (Offers)

Price($) Vol. No.
6.1¢ 17344 1
View Market Depth
Last trade - 16.10pm 10/06/2024 (20 minute delay) ?
Last
6.1¢
  Change
0.001 ( 2.37 %)
Open High Low Volume
5.9¢ 6.1¢ 5.8¢ 7197252
Last updated 15.59pm 10/06/2024 ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.